Teva- Pharmaceutical Industries Ltd. ADR’s filing revealed that its Exec. VP, European Commercial Daniell Richard unloaded Company’s shares for reported $1.13 million on Mar 05 ’25. In the deal valued at $15.91 per share,70,961 shares were sold. As a result of this transaction, Daniell Richard now holds 48,384 shares worth roughly $0.73 million.
Then, Hughes Eric A sold 15,174 shares, generating $238,757 in total proceeds. Upon selling the shares at $15.73, the See “Remarks” now owns 8,077 shares.
Before that, Hughes Eric A sold 8,077 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $128,531 were divested by the See “Remarks” at a price of $15.91 per share. As a result of the transaction, Hughes Eric A now holds 0 shares, worth roughly $0.0.
Argus upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “an Underweight” to “a Neutral”. Piper Sandler also remained covering TEVA and has increased its forecast on February 12, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Jefferies revised its rating on January 23, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.
Price Performance Review of TEVA
On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -2.65% to $15.08. Over the last five days, the stock has lost -6.34%. Teva- Pharmaceutical Industries Ltd. ADR shares have fallen nearly -31.58% since the year began. Nevertheless, the stocks have risen 6.65% over the past one year. While a 52-week high of $22.80 was reached on 01/28/25, a 52-week low of $12.51 was recorded on 03/10/25. SMA at 50 days reached $17.31, while 200 days put it at $17.80.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 14.80, which if violated will result in even more drops to 14.52. On the upside, there is a resistance level at 15.43. A further resistance level may holdings at 15.78. The Relative Strength Index (RSI) on the 14-day chart is 33.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.78%. Stochastics %K at 36.92% indicates the stock is a holding.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-03-14, growing by 8.15 million shares to a total of 34.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 26.66 million shares. There was a rise of 23.4%, which implies that there is a positive sentiment for the stock.
